Clinical Trials for Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)

Find clinical trials for relapsed/refractory (r/r) mature b cell non hodgkin lymphoma (nhl). Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

NCT ID: NCT06393738

This clinical trial is examining a new drug called ARV-393 to see if it is safe and effective for treating advanced forms of non-Hodgkin lymphoma (NHL) that have not responded to previous treatment...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Houston, Texas, United States +20 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions